Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by LSEG. President Donald Trump signed an executive order directing the FDA to expedite review of psychedelics already designated as breakthrough therapy drugs. Joe Rogan and others spoke in the Oval Office about the benefits to veterans' mental health. President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs." "The executive order I'm signing, we're actually signing the executive order today, is really a moment," Trump said. "These treatments are currently in the advanced stages of clinical trials to ensure that they're both safe and effective for the American patients." The president said the executive order would implement "historic reforms to dramatically accelerate access to new medical research and treatments based on psychede